Mode
Text Size
Log in / Sign up

Salivary growth factors differ in type 2 diabetes after tooth extraction

Salivary growth factors differ in type 2 diabetes after tooth extraction
Photo by Mufid Majnun / Unsplash
Key Takeaway
Consider that salivary growth factor responses to tooth extraction may differ in controlled type 2 diabetes, but evidence is preliminary.

This was a prospective observational comparative study with 27 participants: 20 with controlled type 2 diabetes and 7 healthy controls. The intervention was tooth extraction, with healthy controls as the comparator. The primary outcome was salivary growth factor levels (EGF, TGF-α, FGF, PDGF-AB, PDGF-CC, PDGF-DD) before and two days after extraction.

For EGF, there were no significant differences between groups at baseline (p=0.333) or post-extraction (p=0.571). TGF-α levels were not significantly different at baseline (p=0.088) or two days post-extraction (p=0.915). FGF levels showed no significant differences at baseline (p=0.064) or post-extraction (p=0.677). PDGF-DD, PDGF-CC, and PDGF-AB levels decreased in both groups between baseline and the second post-extraction day, except for a slight increase in PDGF-AB in controls; no significant differences between groups were found at baseline or two days post-extraction.

Safety and tolerability were not reported. Key limitations include a small sample size, short follow-up period, and an observational design that cannot establish causality. Practice relevance suggests salivary growth factors are reduced and respond differently in type 2 diabetes, potentially impairing oral wound healing, but supplementation requires further investigation. Findings should be interpreted with caution due to the small cohort and short follow-up.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
This study aimed to evaluate salivary growth factor levels in controlled type 2 diabetic patients compared to healthy individuals, assessed at two time points: before tooth extraction and two days postoperatively. The study included 27 participants: 20 with type 2 diabetes (74.07%) and 7 healthy controls (25.93%). Unstimulated whole saliva samples were collected before tooth extraction and two days afterward. Biomarker analysis was performed using a Luminex multiplex assay, targeting epidermal growth factor (EGF), transforming growth factor-alpha (TGF-α), fibroblast growth factor (FGF), platelet-derived growth factor-AB (PDGF-AB), platelet-derived growth factor-CC (PDGF-CC), and platelet-derived growth factor-DD (PDGF-DD). EGF levels showed no significant differences between groups at baseline (p = 0.333) or post-extraction (p = 0.571); however, two days after extraction, EGF levels almost remained steady in diabetics but decreased in controls. TGF-α was not significantly different between diabetics and control groups at baseline and two days post-extraction (p = 0.088; p = 0.915, respectively), with levels increasing in diabetics and decreasing in controls two days after extraction. FGF levels showed no significant differences at baseline (p = 0.064) or post-extraction (p = 0.677), from baseline to second post-extraction day, the levels were increasing in diabetics and decreasing in controls. Between baseline and the second day post-extraction, the levels of PDGF-DD, PDGF-CC, and PDGF-AB decreased in both groups, except for PDGF-AB in the control group, where a slight increase was observed. No significant differences were found between the diabetic and control groups for PDGF-DD, PDGF-CC, or PDGF-AB at baseline (p = 0.810, p = 0.382, p = 0.881) or two days post-extraction (p = 0.860, p = 0.414, p = 0.740), respectively. Salivary growth factors are reduced and respond differently in type 2 diabetes, potentially contributing to impaired oral wound healing. Supplementing growth factors may improve clinical outcomes, warranting further investigation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.